Cargando…

Intrathecal Inflammation in Progressive Multiple Sclerosis

Progressive forms of multiple sclerosis (MS) are associated with chronic demyelination, axonal loss, neurodegeneration, cortical and deep gray matter damage, and atrophy. These changes are strictly associated with compartmentalized sustained inflammation within the brain parenchyma, the leptomeninge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monaco, Salvatore, Nicholas, Richard, Reynolds, Richard, Magliozzi, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663229/ https://www.ncbi.nlm.nih.gov/pubmed/33153042 http://dx.doi.org/10.3390/ijms21218217

Ejemplares similares

Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study
por: Farina, Gabriele, et al.
Publicado: (2017)

“Ependymal‐in” Gradient of Thalamic Damage in Progressive Multiple Sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2022)

Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation
por: Magliozzi, Roberta, et al.
Publicado: (2021)

B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis
por: Reali, Camilla, et al.
Publicado: (2020)

Aging, Cellular Senescence, and Progressive Multiple Sclerosis
por: Papadopoulos, Dimitrios, et al.
Publicado: (2020)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2019)

Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis
por: Nicholas, Richard, et al.
Publicado: (2016)

Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain
por: Donninelli, Gloria, et al.
Publicado: (2020)

Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2019)

Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients
por: Calabrese, Massimiliano, et al.
Publicado: (2015)

Intrathecal T‐cell clonal expansions in patients with multiple sclerosis
por: de Paula Alves Sousa, Alessandra, et al.
Publicado: (2016)

Repeated Intrathecal Triamcinolone Acetonide Administration in Progressive Multiple Sclerosis: A Review
por: Abu-Mugheisib, Mazen, et al.
Publicado: (2011)

Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
por: Komori, Mika, et al.
Publicado: (2016)

Persistent elevation of intrathecal pro-inflammatory cytokines leads to multiple sclerosis-like cortical demyelination and neurodegeneration
por: James, Rachel E., et al.
Publicado: (2020)

The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome
por: Cooze, Benjamin J., et al.
Publicado: (2022)

No Early Effect of Intrathecal Rituximab in Progressive Multiple Sclerosis (EFFRITE Clinical Trial)
por: Bonnan, Mickael, et al.
Publicado: (2021)

Intrathecal CD8(+)CD20(+) T Cells in Primary Progressive Multiple Sclerosis
por: von Essen, Marina Rode, et al.
Publicado: (2023)

Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis
por: Gajofatto, Alberto, et al.
Publicado: (2013)

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
por: Serafini, Barbara, et al.
Publicado: (2007)

CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2021)

Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms
por: Hellwig, Kerstin, et al.
Publicado: (2004)

CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis
por: Marastoni, Damiano, et al.
Publicado: (2021)

Intrathecal kappa free light chains as markers for multiple sclerosis
por: Vecchio, D., et al.
Publicado: (2020)

Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis
por: Lin, Yen Chih, et al.
Publicado: (2015)

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis
por: Vohl, Katja, et al.
Publicado: (2019)

Association of the retinal vasculature, intrathecal immunity, and disability in multiple sclerosis
por: Noll, Christina, et al.
Publicado: (2022)

Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis
por: Aldarwish, Walaa A., et al.
Publicado: (2023)

Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis
por: Harris, Violaine K., et al.
Publicado: (2018)

Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study
por: Marastoni, Damiano, et al.
Publicado: (2019)

Association between Change in Normal Appearing White Matter Metabolites and Intrathecal Inflammation in Natalizumab-Treated Multiple Sclerosis
por: Mellergård, Johan, et al.
Publicado: (2012)

Intrathecal IgG Synthesis: A Resistant and Valuable Target for Future Multiple Sclerosis Treatments
por: Bonnan, Mickael
Publicado: (2015)

Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis
por: Hoeflich, Andreas, et al.
Publicado: (2020)

Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis
por: DiSano, Krista D, et al.
Publicado: (2020)

Increased Intrathecal Chemokine Receptor CCR2 Expression in Multiple Sclerosis
por: Nakajima, Hideto, et al.
Publicado: (2007)

High prevalence of intrathecal IgA synthesis in multiple sclerosis patients
por: Muñoz, Úrsula, et al.
Publicado: (2022)

Overexpression of the ubiquitin‐editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation
por: Perga, Simona, et al.
Publicado: (2020)

Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis
por: Holm Hansen, Rikke, et al.
Publicado: (2022)

Increase of CSF inflammatory profile in a case of highly active multiple sclerosis
por: Magliozzi, R., et al.
Publicado: (2019)

Multiple Sclerosis Atlas: A Molecular Map of Brain Lesion Stages in Progressive Multiple Sclerosis
por: Frisch, Tobias, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_815jhlf3sdfcoaumkpes3s1v36